Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond

This publication has 95 references indexed in Scilit:

• The AAV Vector Toolkit: Poised at the Clinical Crossroads
  Molecular Therapy, 2012
• Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11
  Molecular Therapy, 2012
• Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis
  Molecular Therapy, 2011
• Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus
  Virus Research, 2011
• Efficient production of Fah -null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer
  Hepatology, 2011
• Adenovirus–Retrovirus Hybrid Vectors Achieve Highly Enhanced Tumor Transduction and Antitumor Efficacy In Vivo
  Molecular Therapy, 2011
• Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
  Molecular Therapy, 2010
• Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
  Cytokine & Growth Factor Reviews, 2010
• Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses
  Gene Therapy, 2010
• Targeting of Adenovirus Serotype 5 Pseudotyped with Short Fiber from Serotype 41 to c-erbB2-Positive Cells using Bispecific Single-Chain Diabody
  Journal of Molecular Biology, 2009